EverSource Wealth Advisors, LLC
Position in TNGX — Tango Therapeutics, Inc.
CIK 1710537
BIRMINGHAM, AL
Position in TNGX
as of Mar 31, 2026
· filed May 18, 2026
Position Value
$544,460
+$317,238 QoQ
Shares Held
26,026
+1.5% QoQ
Ownership
0.018%
of shares outstanding
% of Portfolio
0.04%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2025
5 quarters on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Common Shares in TNGX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026EverSource Wealth Advisors, LLC holds $14,924,651 across 265 Biotechnology names. TNGX ranks #6 (3.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | CRSP |
CRISPR Therapeutics AG
|
89,683 | $4,266,217 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
1,880 | $1,452,556 | |
| 3 | INCY |
Incyte Corp
|
13,070 | $1,230,145 | |
| 4 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
1,507 | $672,929 | |
| 5 | RPRX |
Royalty Pharma plc
|
12,629 | $605,808 | |
| 6 | TNGX |
Tango Therapeutics, Inc.
This page
|
26,026 | $544,460 | |
| 7 | EXEL |
Exelixis, Inc.
|
11,015 | $472,428 | |
| 8 | BMRN |
Biomarin Pharmaceutical Inc
|
6,845 | $386,665 |
All Filings in TNGX
Export CSV
5 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $544,460 | 26,026 | Shares | Sole | 2026-05-18 | |
| 2025-12-31 | $227,222 | 25,646 | Shares | Sole | 2026-02-06 | |
| 2025-09-30 | $223,884 | 26,653 | Shares | Sole | 2025-11-10 | |
| 2025-06-30 | $136,349 | 26,631 | Shares | Sole | 2025-08-13 | |
| 2025-03-31 | $35 | 26 | Shares | Sole | 2025-05-13 | |
| No filing history on record for this holder in this stock. | ||||||